Navigation Links
Trinity Biotech Captia™ B. burgdorferi IgG/IgM ELISA

ProductsTrinity Biotech Captia™ B. burgdorferi IgG/IgM ELISA
Company Trinity Biotech
Item Trinity Biotech Captia™ B. burgdorferi IgG/IgM ELISA
Features 
  • Format : CAPTIA 96 Well
  • Test/Kit : 96 tests
  • FDA : Cleared
  • CE : Cleared
Description The Trinity Biotech Captia Borrelia burgdorferi (B. burgdorferi) IgG/IgM Enzyme Linked Immunosorbent Assay (ELISA) is intended for the qualitative presumptive (firststep) detection of total (IgG/IgM) antibodies to Borrelia burgdorferi in human serum. This ELISA should only be used for patients with signs and symptoms that are consistent with Lyme disease. Equivocal or positive results must be supplemented by testing with a standardized Western-blot (second-step) procedure. Positive supplemental (second- step) results are supportive evidence of exposure to B. burgdorferi and can be used to support a clinical diagnosis of Lyme disease. The diagnosis of Lyme disease must be made based on history, signs (such as erythema migrans), symptoms, and other laboratory data, in addition to the presence of antibodies to B. burgdorferi. Negative results (either first- or second step) should not be used to exclude Lyme disease.
Info Trinity BiotechCall Trinity Biotech to buy products (US and Canada only; other locations use number below) USACanada1-866-328-1174

Customer Service: 1-800-325-3424
Web site: http://www.trinitybiotech.com

Related medicine products :

1. Cambridge Biotech HIV-1 (Western Blot)
2. QualiCode™ B. burgdorferi IgG/IgM Western Blot Kits
3. C6 B. burgdorferi (Lyme) ELISA Kit
4. Lyme C6 B. burgdorferi
5. Lyme B. burgdorferi IgG Western Blot
6. Lyme B. burgdorferi IgM Western Blot
7. Borrelia burgdorferiAntibodies, IgG & IgM by Western Blot
8. Borrelia burgdorferi Antibodies, IgG & IgM by Western Blot (CSF)
9. Borrelia burgdorferi Antibodies, Totalby ELISA
10. Borrelia burgdorferi Antibody, IgG by Western Blot (CSF)
11. Borrelia burgdorferi Antibodies, Total by ELISA (CSF)
Breaking Medicine Technology:Anesiva Completes Sale of its Zingo(TM) Assets to Powder Pharmaceuticals and Lee's Pharmaceuticals 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 2St. Luke's Hospital Acquires Pioneering Technology From BrainLAB 3Al Novak Elected Chairman of the Board of OrbusNeich Medical 2Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 52754 1Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 52754 2Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 52754 3Xoft Expands Cancer Treatment Platform With Launch of Skin Cancer Electronic Brachytherapy Trial at AAPM Meeting 52754 4New Research Reveals the Majority of Parents Overlook Key Steps to Keep Curious Toddlers Safe at Home 52751 1New Research Reveals the Majority of Parents Overlook Key Steps to Keep Curious Toddlers Safe at Home 52751 2New Research Reveals the Majority of Parents Overlook Key Steps to Keep Curious Toddlers Safe at Home 52751 3New Research Reveals the Majority of Parents Overlook Key Steps to Keep Curious Toddlers Safe at Home 52751 4Driven by Launch of Emerging Therapies Overall Prostate Cancer Drug Market Will Increase by 242 Billion Through 2018 52748 1Driven by Launch of Emerging Therapies Overall Prostate Cancer Drug Market Will Increase by 242 Billion Through 2018 52748 2Driven by Launch of Emerging Therapies Overall Prostate Cancer Drug Market Will Increase by 242 Billion Through 2018 52748 3